Works citing this work

2 works

Work: Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

1. Acute cerebrovascular events and inflammatory markers associated with COVID-19: An observational study

   Ibrahim A. Abdelazim, Merey Bakytzhanovna Jumagaliyeva, Dinmukhamed Nurniyazovich Ayaganov +3

   ArticleLong-Term Effects of COVID-19Journal of Medicine and Life20230 citations

   ABIABI:AkademIndex/openalex/2023.article.002473

2. Relationship between severe acute respiratory syndrome coronavirus 2 and diabetes mellitus (review)

   Gulnora Artykbaeva, Saatov Ts

   ArticleAdvanced Glycation End Products researchDiabetes Mellitus20230 citations

   ABIABI:AkademIndex/openalex/2023.article.002990